CGI-1746

For research use only. Not for therapeutic Use.

  • CAT Number: I005423
  • CAS Number: 910232-84-7
  • Molecular Formula: C₃₄H₃₇N₅O₄
  • Molecular Weight: 579.69
  • Purity: ≥95%
Inquiry Now

CGI-1746(Cat No.:I005423)is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), a key enzyme involved in B-cell receptor signaling. By inhibiting BTK, CGI-1746 disrupts the activation of pathways that promote the survival, proliferation, and differentiation of B-cells. This makes it a promising therapeutic candidate for treating B-cell-related malignancies such as chronic lymphocytic leukemia (CLL) and autoimmune diseases like rheumatoid arthritis. CGI-1746 has shown efficacy in preclinical models by reducing inflammation and immune response, offering potential in targeting conditions driven by abnormal B-cell activation.


Catalog Number I005423
CAS Number 910232-84-7
Synonyms

CGI1746

Molecular Formula C₃₄H₃₇N₅O₄
Purity ≥95%
Target BTK
Solubility in DMSO > 10 mM
Storage Store at -20°C
IUPAC Name 4-tert-butyl-N-[2-methyl-3-[4-methyl-6-[4-(morpholine-4-carbonyl)anilino]-5-oxopyrazin-2-yl]phenyl]benzamide
InChI InChI=1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-13-25(14-10-23)34(2,3)4)29-21-38(5)33(42)30(36-29)35-26-15-11-24(12-16-26)32(41)39-17-19-43-20-18-39/h6-16,21H,17-20H2,1-5H3,(H,35,36)(H,37,40)
InChIKey JIFCFQDXHMUPGP-UHFFFAOYSA-N
SMILES CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C(C)(C)C)C3=CN(C(=O)C(=N3)NC4=CC=C(C=C4)C(=O)N5CCOCC5)C
Reference

[1]. Di Paolo, Julie A. et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nature Chemical Biology (2011), 7(1), 41-50

Request a Quote